| Jamie Beth Goldberg, ACNP/PMHNP | |
|
1083 W Park Ave, Anaconda, MT 59711-2000 | |
| (406) 498-5449 | |
| Not Available |
| Full Name | Jamie Beth Goldberg |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 1083 W Park Ave, Anaconda, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255875811 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 116142 (Montana) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 116142 (Montana) | Primary |
| Entity Name | Cogent Healthcare Of Montana P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053569525 PECOS PAC ID: 4486712833 Enrollment ID: O20081029000254 |
News Archive
Emisphere Technologies, Inc. (OTC BB: EMIS) today announced that it has received commitments from two institutional investors to purchase $4 million of securities in a registered direct offering. Emisphere entered into a securities purchase agreement with these investors pursuant to which Emisphere has agreed to sell an aggregate of 5,714,286 shares of its common stock and warrants to purchase up to 2,685,714 additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.47 of a share of common stock, will be sold for a purchase price of $0.70.
The US Food and Drug Administration has announced the expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia (CLL). Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy. Diplomat has access to dispense Arzerra.
Eight IOF Young Investigator Awards were presented by the International Osteoporosis Foundation (IOF) to young researchers from Australia, China, India and Japan, in recognition of their outstanding work. The awards, valued at 1,000 USD each, were awarded to the highest scored abstracts by researchers under the age of 40.
Health officials in Brazil on Sunday began distributing millions of condoms ahead of the country's five-day Carnival in an effort to reduce the spread of HIV and other sexually transmitted infections, the AP/San Diego Union-Tribune reports.
› Verified 9 days ago
| Entity Name | Ideal Option Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457788275 PECOS PAC ID: 6709013105 Enrollment ID: O20160929000987 |
News Archive
Emisphere Technologies, Inc. (OTC BB: EMIS) today announced that it has received commitments from two institutional investors to purchase $4 million of securities in a registered direct offering. Emisphere entered into a securities purchase agreement with these investors pursuant to which Emisphere has agreed to sell an aggregate of 5,714,286 shares of its common stock and warrants to purchase up to 2,685,714 additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.47 of a share of common stock, will be sold for a purchase price of $0.70.
The US Food and Drug Administration has announced the expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia (CLL). Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy. Diplomat has access to dispense Arzerra.
Eight IOF Young Investigator Awards were presented by the International Osteoporosis Foundation (IOF) to young researchers from Australia, China, India and Japan, in recognition of their outstanding work. The awards, valued at 1,000 USD each, were awarded to the highest scored abstracts by researchers under the age of 40.
Health officials in Brazil on Sunday began distributing millions of condoms ahead of the country's five-day Carnival in an effort to reduce the spread of HIV and other sexually transmitted infections, the AP/San Diego Union-Tribune reports.
› Verified 9 days ago
| Entity Name | Ideal Telemedicine Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346754868 PECOS PAC ID: 2860726221 Enrollment ID: O20190708000200 |
News Archive
Emisphere Technologies, Inc. (OTC BB: EMIS) today announced that it has received commitments from two institutional investors to purchase $4 million of securities in a registered direct offering. Emisphere entered into a securities purchase agreement with these investors pursuant to which Emisphere has agreed to sell an aggregate of 5,714,286 shares of its common stock and warrants to purchase up to 2,685,714 additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.47 of a share of common stock, will be sold for a purchase price of $0.70.
The US Food and Drug Administration has announced the expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia (CLL). Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy. Diplomat has access to dispense Arzerra.
Eight IOF Young Investigator Awards were presented by the International Osteoporosis Foundation (IOF) to young researchers from Australia, China, India and Japan, in recognition of their outstanding work. The awards, valued at 1,000 USD each, were awarded to the highest scored abstracts by researchers under the age of 40.
Health officials in Brazil on Sunday began distributing millions of condoms ahead of the country's five-day Carnival in an effort to reduce the spread of HIV and other sexually transmitted infections, the AP/San Diego Union-Tribune reports.
› Verified 9 days ago
| Entity Name | Hospitalist Medicine Physicians Of Nebraska-tcg, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487133963 PECOS PAC ID: 7911333810 Enrollment ID: O20200213001396 |
News Archive
Emisphere Technologies, Inc. (OTC BB: EMIS) today announced that it has received commitments from two institutional investors to purchase $4 million of securities in a registered direct offering. Emisphere entered into a securities purchase agreement with these investors pursuant to which Emisphere has agreed to sell an aggregate of 5,714,286 shares of its common stock and warrants to purchase up to 2,685,714 additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.47 of a share of common stock, will be sold for a purchase price of $0.70.
The US Food and Drug Administration has announced the expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia (CLL). Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy. Diplomat has access to dispense Arzerra.
Eight IOF Young Investigator Awards were presented by the International Osteoporosis Foundation (IOF) to young researchers from Australia, China, India and Japan, in recognition of their outstanding work. The awards, valued at 1,000 USD each, were awarded to the highest scored abstracts by researchers under the age of 40.
Health officials in Brazil on Sunday began distributing millions of condoms ahead of the country's five-day Carnival in an effort to reduce the spread of HIV and other sexually transmitted infections, the AP/San Diego Union-Tribune reports.
› Verified 9 days ago
| Entity Name | Wellness Options Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356032387 PECOS PAC ID: 8426403197 Enrollment ID: O20231016002505 |
News Archive
Emisphere Technologies, Inc. (OTC BB: EMIS) today announced that it has received commitments from two institutional investors to purchase $4 million of securities in a registered direct offering. Emisphere entered into a securities purchase agreement with these investors pursuant to which Emisphere has agreed to sell an aggregate of 5,714,286 shares of its common stock and warrants to purchase up to 2,685,714 additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.47 of a share of common stock, will be sold for a purchase price of $0.70.
The US Food and Drug Administration has announced the expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia (CLL). Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy. Diplomat has access to dispense Arzerra.
Eight IOF Young Investigator Awards were presented by the International Osteoporosis Foundation (IOF) to young researchers from Australia, China, India and Japan, in recognition of their outstanding work. The awards, valued at 1,000 USD each, were awarded to the highest scored abstracts by researchers under the age of 40.
Health officials in Brazil on Sunday began distributing millions of condoms ahead of the country's five-day Carnival in an effort to reduce the spread of HIV and other sexually transmitted infections, the AP/San Diego Union-Tribune reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jamie Beth Goldberg, ACNP/PMHNP 1083 W Park Ave, Anaconda, MT 59711-2000 Ph: (406) 498-5449 | Jamie Beth Goldberg, ACNP/PMHNP 1083 W Park Ave, Anaconda, MT 59711-2000 Ph: (406) 498-5449 |
News Archive
Emisphere Technologies, Inc. (OTC BB: EMIS) today announced that it has received commitments from two institutional investors to purchase $4 million of securities in a registered direct offering. Emisphere entered into a securities purchase agreement with these investors pursuant to which Emisphere has agreed to sell an aggregate of 5,714,286 shares of its common stock and warrants to purchase up to 2,685,714 additional shares of its common stock. Each unit, consisting of one share of common stock and a warrant to purchase 0.47 of a share of common stock, will be sold for a purchase price of $0.70.
The US Food and Drug Administration has announced the expanded approval of Arzerra (ofatumumab) in combination with chlorambucil for the first-line treatment of chronic lymphocytic leukemia (CLL). Arzerra was previously approved by the FDA in October 2009 for the treatment of CLL resistant to other forms of chemotherapy. Diplomat has access to dispense Arzerra.
Eight IOF Young Investigator Awards were presented by the International Osteoporosis Foundation (IOF) to young researchers from Australia, China, India and Japan, in recognition of their outstanding work. The awards, valued at 1,000 USD each, were awarded to the highest scored abstracts by researchers under the age of 40.
Health officials in Brazil on Sunday began distributing millions of condoms ahead of the country's five-day Carnival in an effort to reduce the spread of HIV and other sexually transmitted infections, the AP/San Diego Union-Tribune reports.
› Verified 9 days ago
Katherine Bugni, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 205 E Park Ave, Anaconda, MT 59711 Phone: 406-563-8117 | |
Mrs. Deborah Kalarchik, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 401 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-8528 Fax: 406-563-8694 | |
Colleen Todorovich, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 118 E 7th St, Suite 2a, Anaconda, MT 59711 Phone: 406-496-3000 Fax: 406-496-3030 | |
Ms. Kathleen A Russell, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 110 Oak St, Anaconda, MT 59711 Phone: 406-563-0071 Fax: 406-563-0774 | |
Stacie R Connors, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 305 W Pennsylvania Ave, Anaconda, MT 59711 Phone: 406-563-7337 Fax: 406-563-8338 | |
Cyril J Schaefer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 401 W Pennsylvania St, Anaconda, MT 59711 Phone: 406-563-8686 Fax: 406-563-8691 |